Literature DB >> 17627773

Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection.

Kehmia Titanji1, Stefano Sammicheli, Angelo De Milito, Paola Mantegani, Claudio Fortis, Louise Berg, Klas Kärre, Giovanna Travi, Chiara Tassandin, Lucia Lopalco, Bence Rethi, Giuseppe Tambussi, Francesca Chiodi.   

Abstract

Human natural killer (NK) (CD3- CD56+) cells can be divided into two functionally distinct subsets, CD3- CD56(dim) and CD3- CD56(bright). We analysed the distribution of NK cell subsets in primary and chronic human immunodeficiency virus-1 (HIV-1) infection, to determine if HIV infection stage may influence the subset distribution. In primary infection, contrary to chronic infection, the CD3- CD56(dim) subset was expanded compared to healthy controls. We also studied the effect of antiretroviral therapy administered early in infection and found that NK cell subset distribution was partially restored after 6 months of antiretroviral therapy in primary infection, but not normalized. Recently, NK cells have been divided into CD27- and CD27+ subsets with different migratory and functional capacity and CD27-mediated NK cell activation has been described in mice. We therefore investigated whether CD27 and/or CD70 (CD27 ligand) expression on NK cells, and thus the distribution of these novel NK subsets, was altered in HIV-1-infected patients. We found up-regulated expression of both CD27 and CD70 on NK cells of patients, resulting in higher proportions of CD27(high) and CD70(high) NK cells, and this phenomenon was more pronounced in chronic infection. Experiments conducted in vitro suggest that the high interleukin-7 levels found during HIV-1 infection may participate in up-regulation of CD70 on NK cell subsets. Imbalance of NK cell subsets and up-regulated expression of CD27 and CD70 initiated early in HIV-1 infection may indicate NK cell activation and intrinsic defects initiated by HIV-1 to disarm the innate immune response to the virus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627773      PMCID: PMC2433301          DOI: 10.1111/j.1365-2567.2007.02657.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

Review 1.  CD27 and CD70 in T cell and B cell activation.

Authors:  Jannie Borst; Jenny Hendriks; Yanling Xiao
Journal:  Curr Opin Immunol       Date:  2005-06       Impact factor: 7.486

2.  Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.

Authors:  Galit Alter; Nickolas Teigen; Benjamin T Davis; Marylyn M Addo; Todd J Suscovich; Michael T Waring; Hendrik Streeck; Mary N Johnston; Kyle D Staller; M Tauheed Zaman; Xu G Yu; Mathias Lichterfeld; Nesli Basgoz; Eric S Rosenberg; Marcus Altfeld
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

3.  Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo.

Authors:  Christian A J Vosshenrich; Thomas Ranson; Sandrine I Samson; Erwan Corcuff; Francesco Colucci; Eleftheria E Rosmaraki; James P Di Santo
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

4.  Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients.

Authors:  Bence Rethi; Caroline Fluur; Ann Atlas; Malgorzata Krzyzowska; Frida Mowafi; Sven Grützmeier; Angelo De Milito; Rino Bellocco; Kerstin I Falk; Eva Rajnavölgyi; Francesca Chiodi
Journal:  AIDS       Date:  2005-12-02       Impact factor: 4.177

5.  Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions.

Authors:  Kehmia Titanji; Francesca Chiodi; Rino Bellocco; Danika Schepis; Lyda Osorio; Chiara Tassandin; Giuseppe Tambussi; Sven Grutzmeier; Lucia Lopalco; Angelo De Milito
Journal:  AIDS       Date:  2005-11-18       Impact factor: 4.177

Review 6.  NK cells in HIV infection: paradigm for protection or targets for ambush.

Authors:  Anthony S Fauci; Domenico Mavilio; Shyam Kottilil
Journal:  Nat Rev Immunol       Date:  2005-11       Impact factor: 53.106

7.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

Authors:  Domenico Mavilio; Gabriella Lombardo; Janet Benjamin; Diana Kim; Dean Follman; Emanuela Marcenaro; M Angeline O'Shea; Audrey Kinter; Colin Kovacs; Alessandro Moretta; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

8.  Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients.

Authors:  Manuela Fogli; Paola Costa; Giuseppe Murdaca; Maurizio Setti; Maria Cristina Mingari; Lorenzo Moretta; Alessandro Moretta; Andrea De Maria
Journal:  Eur J Immunol       Date:  2004-08       Impact factor: 5.532

9.  Increased natural killer cell activity in viremic HIV-1 infection.

Authors:  Galit Alter; Jessica M Malenfant; Rosemary M Delabre; Nicole C Burgett; Xu G Yu; Mathias Lichterfeld; John Zaunders; Marcus Altfeld
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

10.  CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patients.

Authors:  Adrian F Ochsenbein; Stanley R Riddell; Michele Brown; Lawrence Corey; Gabriela M Baerlocher; Peter M Lansdorp; Philip D Greenberg
Journal:  J Exp Med       Date:  2004-12-06       Impact factor: 14.307

View more
  13 in total

1.  Higher NK cell IFN-γ production is associated with delayed HIV disease progression in LTNPs.

Authors:  Yongjun Jiang; Fangyuan Zhou; Yao Tian; Zining Zhang; Rongmei Kuang; Jing Liu; Xiaoxu Han; Qinghai Hu; Junjie Xu; Hong Shang
Journal:  J Clin Immunol       Date:  2013-09-03       Impact factor: 8.317

2.  Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus.

Authors:  Danika Schepis; Iva Gunnarsson; Maija-Leena Eloranta; Jon Lampa; Stefan H Jacobson; Klas Kärre; Louise Berg
Journal:  Immunology       Date:  2008-06-18       Impact factor: 7.397

3.  Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.

Authors:  Christopher W Pohlmeyer; Veronica D Gonzalez; Alivelu Irrinki; Ricardo N Ramirez; Li Li; Andrew Mulato; Jeffrey P Murry; Aaron Arvey; Rebecca Hoh; Steven G Deeks; George Kukolj; Tomas Cihlar; Stefan Pflanz; Garry P Nolan; Gundula Min-Oo
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

4.  Multiparameter flow cytometry for discovery of disease mechanisms in rheumatic diseases.

Authors:  Mark J Soloski; Francis J Chrest
Journal:  Arthritis Rheum       Date:  2013-05

5.  Innate immune responses in primary HIV-1 infection.

Authors:  Persephone Borrow; Nina Bhardwaj
Journal:  Curr Opin HIV AIDS       Date:  2008-01       Impact factor: 4.283

6.  Perturbation of the natural killer cell compartment during primary human immunodeficiency virus 1 infection primarily involving the CD56 bright subset.

Authors:  Paola Mantegani; Giuseppe Tambussi; Laura Galli; Chiara Tassan Din; Adriano Lazzarin; Claudio Fortis
Journal:  Immunology       Date:  2009-08-04       Impact factor: 7.397

7.  Systemic effector and regulatory immune responses to chlamydial antigens in trachomatous trichiasis.

Authors:  Alevtina Gall; Amir Horowitz; Hassan Joof; Angels Natividad; Kevin Tetteh; Eleanor Riley; Robin L Bailey; David C W Mabey; Martin J Holland
Journal:  Front Microbiol       Date:  2011-02-10       Impact factor: 5.640

8.  Quantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infection.

Authors:  Marjet Elemans; Rodolphe Thiébaut; Amitinder Kaur; Becca Asquith
Journal:  PLoS Comput Biol       Date:  2011-03-03       Impact factor: 4.475

9.  HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).

Authors:  Sanne Skov Jensen; Anders Fomsgaard; Marie Borggren; Jeanette Linnea Tingstedt; Jan Gerstoft; Gitte Kronborg; Line Dahlerup Rasmussen; Court Pedersen; Ingrid Karlsson
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

10.  An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells.

Authors:  Nicole A P Lieberman; Kole DeGolier; Kristen Haberthur; Harrison Chinn; Kara W Moyes; Myriam N Bouchlaka; Kirsti L Walker; Christian M Capitini; Courtney A Crane
Journal:  Front Immunol       Date:  2018-02-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.